NASDAQ:INM | Insider Transactions — Page 2 | InMed Pharmaceuticals Inc.

INM Insider Transactions — Page 2

140 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–140; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Vivo Opportunity Cayman, LLCTenPercentOwner2026-05-29Purchase1,632.0$1.57
Vivo Opportunity Fund Holdings, L.P.TenPercentOwner2026-05-29Purchase1,632.0$1.57
Vivo Opportunity, LLCTenPercentOwner2026-05-29Purchase16,164.0$1.57
Vivo Opportunity Cayman Fund, L.P.TenPercentOwner2026-05-29Purchase16,164.0$1.57
Vivo Opportunity Cayman, LLCTenPercentOwner2026-05-29Purchase16,164.0$1.57
Vivo Opportunity Fund Holdings, L.P.TenPercentOwner2026-05-29Purchase16,164.0$1.57
Vivo Opportunity, LLCTenPercentOwner2026-05-21Purchase3,118.0$1.69
Vivo Opportunity Cayman Fund, L.P.TenPercentOwner2026-05-21Purchase3,118.0$1.69
Vivo Opportunity Cayman, LLCTenPercentOwner2026-05-21Purchase3,118.0$1.69
Vivo Opportunity Fund Holdings, L.P.TenPercentOwner2026-05-21Purchase3,118.0$1.69
Vivo Opportunity, LLCTenPercentOwner2026-05-21Purchase30,882.0$1.69
Vivo Opportunity Cayman Fund, L.P.TenPercentOwner2026-05-21Purchase30,882.0$1.69
Vivo Opportunity Cayman, LLCTenPercentOwner2026-05-21Purchase30,882.0$1.69
Vivo Opportunity Fund Holdings, L.P.TenPercentOwner2026-05-21Purchase30,882.0$1.69
Vivo Opportunity, LLCTenPercentOwner2026-05-20Purchase5,154.0$1.56
Vivo Opportunity Cayman Fund, L.P.TenPercentOwner2026-05-20Purchase5,154.0$1.56
Vivo Opportunity Cayman, LLCTenPercentOwner2026-05-20Purchase5,154.0$1.56
Vivo Opportunity Fund Holdings, L.P.TenPercentOwner2026-05-20Purchase5,154.0$1.56
Vivo Opportunity, LLCTenPercentOwner2026-05-20Purchase51,056.0$1.56
Vivo Opportunity Cayman Fund, L.P.TenPercentOwner2026-05-20Purchase51,056.0$1.56
Vivo Opportunity Cayman, LLCTenPercentOwner2026-05-20Purchase51,056.0$1.56
Vivo Opportunity Fund Holdings, L.P.TenPercentOwner2026-05-20Purchase51,056.0$1.56
Schneeberger DanielTenPercentOwner2026-05-19Purchase200,000.0$1.5
ADAR1 Capital Management, LLCTenPercentOwner2026-05-19Purchase200,000.0$1.5
Schneeberger DanielTenPercentOwner2026-05-19Purchase200,000.0$1.56
ADAR1 Capital Management, LLCTenPercentOwner2026-05-19Purchase200,000.0$1.56
Schneeberger DanielTenPercentOwner2026-05-19Purchase68,551.0$1.6
ADAR1 Capital Management, LLCTenPercentOwner2026-05-19Purchase68,551.0$1.6
MANCINI ALEXANDRA DIANE JANETOther2024-07-31Sale240.0$0.18
HULL ANDREWDirector2024-02-21Purchase37,500.0$0.39
ADAMS ERIC APresident & CEO2024-02-20Purchase41,600.0$0.36
ADAMS ERIC APresident & CEO2022-04-14Purchase14,160.0$0.89
ADAMS ERIC APresident & CEO2022-04-13Purchase8,560.0$0.85
COLWILL BRUCECFO2022-01-24Purchase5,000.0$1.09
Johnson Shane AaronSVP, GM of BayMedica LLC2022-01-06Purchase8,500.0$1.26
Johnson Shane AaronSVP, GM of BayMedica LLC2021-12-30Purchase8,093.0$1.33
Johnson Shane AaronSVP, GM of BayMedica LLC2021-11-15Purchase5,000.0$1.37
ADAMS ERIC APresident & CEO2021-09-29Purchase8,800.0$1.73
ADAMS ERIC APresident & CEO2021-09-28Purchase11,400.0$1.75
COLWILL BRUCECFO2021-09-28Purchase5,000.0$1.77